Full text is available at the source.
Abstract
The risk of diabetic retinopathy and kidney disease may differ between once-daily liraglutide and once-weekly dulaglutide in Japanese participants with type 2 diabetes.
- Diabetic retinopathy is a common complication of type 2 diabetes that affects vision.
- Kidney disease is another serious complication associated with diabetes.
- Liraglutide is administered daily, while dulaglutide is given weekly.
- Comparative evaluations of these medications could provide insights into their safety profiles.
Simplified